-transparent.png){kind=logo}
A chemotherapeutic combination associating vincristine, adriamycin, procarbazine and prednisone (VAPP) was evaluated in Hodgkin's disease. Subjects were either far advanced cases or relapsing after MOPP and/or radiation therapy. 50 cases were evaluable. After 6 months of treatment 80% of the cases achieved a complete remission. After 30 months 87% of the patients still survive and 60% were still in complete remission. The good tolerance of this chemotherapeutic combination and the results described above, suggest that VAPP may be useful in all cases when MOPP is not well tolerated or is not active.
Related Publications
G Marinone, and
R Colle, and
P Mombelloni
May 1990,
Cancer,
G Marinone, and
R Colle, and
P Mombelloni
November 1991,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
G Marinone, and
R Colle, and
P Mombelloni
October 1975,
Cancer,
G Marinone, and
R Colle, and
P Mombelloni
December 1998,
Blood,
G Marinone, and
R Colle, and
P Mombelloni
December 1970,
Blood,
G Marinone, and
R Colle, and
P Mombelloni
May 1983,
Cancer treatment reports,
G Marinone, and
R Colle, and
P Mombelloni
March 1996,
Gan to kagaku ryoho. Cancer & chemotherapy,
G Marinone, and
R Colle, and
P Mombelloni
January 1984,
Cancer treatment reports,
G Marinone, and
R Colle, and
P Mombelloni
November 1982,
Gan to kagaku ryoho. Cancer & chemotherapy,
G Marinone, and
R Colle, and
P Mombelloni
September 1983,
Cancer treatment reports,
